Dr. Bradford Alan Perez, MD

Dr. Perez practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Perez's NPI, 1578887725, was assigned on March 17, 2010. Dr. Perez graduated from Duke University School Of Medicine in 2010. Dr. Perez holds Florida license ME123804.

Dr. Perez's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Perez's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Perez is also affiliated with HCA Florida Trinity Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Perez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perez practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Perez's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Perez is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Perez's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists bladder cancer radiation, bone cancer radiation, colorectal cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Perez treats.

CMS data shows 7,473 Medicare services from Dr. Perez across 23 procedure codes in 2024, for 202 Medicare patients. Medicare paid $1,275,941 for them. Every service was in an office.

CMS counts 202 Medicare patients who saw Dr. Perez in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perez's median patient age at 69, with 65% women.

In 2024, Dr. Perez wrote 275 Medicare Part D claims for 127 patients. 93% of them were for generic drugs. CMS names the drug for 168 of them, across 8 drugs with 11 or more claims each, at $2,599 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Perez for performance year 2024, reported as part of a group. Dr. Perez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 53 papers to Dr. Perez, published from 2013 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Radiosurgery. Dr. Perez has published most often in Int J Radiat Oncol Biol Phys. Dr. Perez's most frequent co-authors are Thomas J. Dilling, MD, Scott Joseph Antonia, MD and Arash Olyie Naghavi, MD.

Dmand AI links Dr. Perez to 9 clinical trials, 3 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Small Cell Lung Carcinoma and Carcinoma, Non-Small-Cell Lung. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 3.

CMS Open Payments shows 219 general payments to Dr. Perez from 35 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 66% of the total. AstraZeneca Pharmaceuticals LP paid the most, $34,511.

Dr. Perez graduated from Duke University School Of Medicine in 2010. Dr. Perez is a member of AOA and ASTRO.

Dr. Perez is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.